Something has been sitting with me this week. It started with the splash pad story, the one about the 16-month-old in Arkansas and a chlorinator that had been broken for a month. I keep thinking about how long that month was. How many afternoons. How many parents who had no way to know.
I grew up trusting that the boring infrastructure under public life mostly worked. The pool was clean because someone cleaned it. The sunscreen on the shelf was safe because someone checked. You learn, slowly, that “someone” is often nobody in particular, and the catch is meant to happen at a layer that nobody has been funding.
That feeling crept into the rest of the week’s reading. A sunscreen filter Europe approved back when I was a kid finally cleared the FDA on Tuesday, more than two decades after the paperwork landed. In the meantime, Americans were rubbing on ingredients the agency’s own review could not bring itself to call safe. Nothing dramatic. Nothing actionable. Just a quiet, decades-long gap between what was possible and what we got.
I do not have a tidy lesson for any of it. Mostly I want to say, this week, that I notice these gaps. I think you do too.
Autoimmune & Inflammation
A near-starvation diet shifted inflammation in gum-disease patients. The trial was tiny, and the diet came in a box.
A 28-patient feasibility trial put severe gum-disease patients on three cycles of a 750-calorie ProLon diet. Inflammation markers trended lower; clinical gum measures weren’t reported. The biology question is real; the data is thin.
Fish oil rewired the T-cells in non-obese diabetic rats, and the glucose moved with them
A Brazilian team gave EPA-heavy fish oil to a non-obese diabetic rat strain for eight weeks. Glucose, insulin sensitivity, and lipids all moved in the friendlier direction. The T-cell balance shifted alongside them, and that is the part of the paper worth chewing on.
Investigations
A 16-Foot Fire Tornado Burned an Oil Slick With 40% Less Soot. Cleanup Crews Have Been Breathing the Same Old Smoke Since the Exxon Valdez.
A federally funded field trial used a controlled fire whirl to burn up to 95% of a crude oil pool while cutting soot by 40%, raising the question of why the standard in-situ burn, with its measured worker-lung cost, has gone unchallenged for thirty-five years.
A Senate Subcommittee Just Put the COVID Shot Cancer Question on the Record
A Senate Homeland Security subcommittee took testimony on whether mRNA COVID shots can plausibly cause cancer, and on the parallel campaign to keep that question out of the journals. Dr. John Campbell walked his audience through it.
Drugs & FDA
Medicare’s Product-Hopping Loophole Is Back On The Chopping Block. The Bigger Pharma Giveaway Isn’t.
The Trump administration on Thursday proposed closing the product-hopping loophole that lets drugmakers reset Medicare’s negotiation clock by tweaking inactive ingredients. It is the same fix the same administration quietly tabled in October.
Europe had this sunscreen in 1999. The FDA approved it Tuesday.
A new chemical UV filter Europe approved in 1999 just cleared the FDA after a 21-year wait, while Americans relied on ingredients the agency’s own 2019 review could not call safe.
Cancer
A Korean lab found cancer’s DNA-repair off-switch. In a mouse.
A Korean state lab reports that a tool compound called UNI418 strips out the DNA-repair proteins cancer cells use to escape PARP inhibitors. The data are preclinical: cell lines and mouse xenografts. UNI418 is not yet a drug.
ALTAIR Missed Its Primary Endpoint. The Press Tour Found Something Else.
A phase 3 trial testing chemotherapy in ctDNA-positive colorectal cancer patients missed its primary endpoint at p=0.107, and a post-hoc reanalysis is doing the public-facing work.
Infectious Disease
The AI Vaccine That ‘Passed’ Its First Trial Three Years Ago
Cambridge finished the Phase 1 trial in 2023. The press tour arrived in 2026. The paper, when you read it, said the immunogenicity was modest.
A 16-month-old died at an Arkansas splash pad. Its chlorinator had been broken for a month.
A new global synthesis on free-living amoebae explains why a single bad month at a public splash pad is enough to kill a child, and why the CDC’s existing protocol would have caught it.
Metabolic & Weight
Lilly’s triple agonist hit 30% weight loss. The glucagon bet is why.
Lilly’s triple agonist hit nearly 30% weight loss at 104 weeks at ADA 2026. The glucagon bet is what makes retatrutide different from semaglutide and Mounjaro, and it’s what makes the open safety signals different too.
Retatrutide’s Triple-Receptor Triumph Came With a One-in-Five Skin-Sensation Signal Nobody Wanted to Linger On
Eli Lilly’s investigational retatrutide hit bariatric-surgery-level weight loss at ADA 2026. The highest-dose arm of TRIUMPH-4 also saw 20.9% of patients report abnormal skin sensations, and a small cardiac imbalance turned up in the type-2 trial. Both got far less stage time than the headline numbe
Brain & Aging
The Same Mutations That Drive Blood Cancer Keep Turning Up in Alzheimer’s Brains
A new Cell paper finds Alzheimer’s brains are riddled with the same mutations that drive blood cancers, in the immune cells that are supposed to be protecting neurons.
Disappointment, Not Reward, Is What Breaks a Habit. Half of Older Adults Are on Drugs That Blunt Acetylcholine.
An OIST team caught the mouse brain firing acetylcholine the moment an expected reward failed to land. That surge is what lets the animal switch strategy. Close to half of community-dwelling older adults are on drugs that block the same receptors.
Nutrition & Food
8,300 Brazilian elders, one saltshaker, and the 80 percent of sodium nobody mentions
A Frontiers in Public Health survey of 8,336 Brazilians over 60 found older men reach for the saltshaker most. Buried in the same paper: the shaker only accounts for 6 to 20 percent of total sodium. The other 70-plus percent already arrived from the factory.
American Doctors Get About 1.2 Hours of Nutrition Training a Year. RFK Jr. Just Found the Lever.
Kennedy got eight organizations across U.S. medical training and 73 medical schools to commit to nutrition in licensing, accreditation, and a 40-hour pledge. The board exam matters; the rest is partly hedging.